• Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

  • Jul 24 2024
  • Length: 39 mins
  • Podcast

Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

Listen for free

View show details

  • Summary

  • Rerun:

    “I'm very concerned that European citizens will have lack of access or much lower access to some of the new medicines” says CEO of Novo Nordisk. He also share some interesting perspectives about the importance of purpose and their new weight loss drug.

    The production team on this episode were PLAN-B’s Niklas Figenschau Johansen and Nikolai Ovenberg. Background research was done by Sigurd Brekke with input from portfolio manager Gemma Game.


    • Watch the episode on YouTube: Norges Bank Investment Management - YouTube
    • Want to learn more about the fund? The fund | Norges Bank Investment Management (nbim.no)
    • Follow Nicolai Tangen on LinkedIn: Nicolai Tangen | LinkedIn
    • Follow NBIM on LinkedIn: Norges Bank Investment Management: Administrator for bedriftsside | LinkedIn
    • Follow NBIM on Instagram: Explore Norges Bank Investment Management on Instagram



    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
Economics
Show more Show less

What listeners say about Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available